159 related articles for article (PubMed ID: 29112075)
1. Consequences of a changing US strategy in the global HIV investment landscape.
McGillen JB; Sharp A; Honermann B; Millett G; Collins C; Hallett TB
AIDS; 2017 Nov; 31(18):F19-F23. PubMed ID: 29112075
[TBL] [Abstract][Full Text] [Related]
2. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
[TBL] [Abstract][Full Text] [Related]
3. Optimum resource allocation to reduce HIV incidence across sub-Saharan Africa: a mathematical modelling study.
McGillen JB; Anderson SJ; Dybul MR; Hallett TB
Lancet HIV; 2016 Sep; 3(9):e441-e448. PubMed ID: 27562745
[TBL] [Abstract][Full Text] [Related]
4. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
Agonnoude MT; Mesenge C
Sante; 2010; 20(2):116-24. PubMed ID: 20685643
[TBL] [Abstract][Full Text] [Related]
5. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
Williams BG; Gupta S; Wollmers M; Granich R
Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
[TBL] [Abstract][Full Text] [Related]
6. Innovative financing for HIV response in sub-Saharan Africa.
Atun R; Silva S; Ncube M; Vassall A
J Glob Health; 2016 Jun; 6(1):010407. PubMed ID: 27231543
[TBL] [Abstract][Full Text] [Related]
7. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
[TBL] [Abstract][Full Text] [Related]
8. Combatting HIV and AIDS in sub-Saharan Africa.
Manfrin V
Lancet; 2001 Apr; 357(9265):1364-5. PubMed ID: 11347583
[No Abstract] [Full Text] [Related]
9. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.
Atun R; Chang AY; Ogbuoji O; Silva S; Resch S; Hontelez J; Bärnighausen T
BMJ Open; 2016 Mar; 6(3):e009656. PubMed ID: 26948960
[TBL] [Abstract][Full Text] [Related]
10. Combatting HIV and AIDS in sub-Saharan Africa.
Müller O; Jordan B; Vogel U
Lancet; 2001 Apr; 357(9265):1364. PubMed ID: 11347582
[No Abstract] [Full Text] [Related]
11. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
Gentilini M; Chieze F
Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
[TBL] [Abstract][Full Text] [Related]
12. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
13. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.
Resch S; Ryckman T; Hecht R
Lancet Glob Health; 2015 Jan; 3(1):e52-61. PubMed ID: 25539970
[TBL] [Abstract][Full Text] [Related]
14. Financing HIV/AIDS programs in sub-Saharan Africa.
Haacker M
Health Aff (Millwood); 2009; 28(6):1606-16. PubMed ID: 19887402
[TBL] [Abstract][Full Text] [Related]
15. Operative needs in HIV+ populations: An estimation for sub-Saharan Africa.
Cherewick ML; Cherewick SD; Kushner AL
Surgery; 2017 May; 161(5):1436-1443. PubMed ID: 28043694
[TBL] [Abstract][Full Text] [Related]
16. USA spearheads renewed efforts to combat AIDS.
Ashraf H
Lancet; 2000 Jan; 355(9199):211. PubMed ID: 10675132
[TBL] [Abstract][Full Text] [Related]
17. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
Kerouedan D
Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
[TBL] [Abstract][Full Text] [Related]
18. [HIV/AIDS epidemics in sub-Saharan regions in the 2010s: Regional analysis of UNAIDS data].
Preis J; Čechurová M
Epidemiol Mikrobiol Imunol; 2016; 65(3):198-205. PubMed ID: 27690478
[TBL] [Abstract][Full Text] [Related]
19. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.
Hontelez JA; Chang AY; Ogbuoji O; de Vlas SJ; Bärnighausen T; Atun R
AIDS; 2016 Sep; 30(15):2341-50. PubMed ID: 27367487
[TBL] [Abstract][Full Text] [Related]
20. The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research.
Zachariah R; Van Damme W; Arendt V; Schmit JC; Harries AD
J Int AIDS Soc; 2011 Jul; 14 Suppl 1():S7. PubMed ID: 21967983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
